Current NDC auxiliary source row compounder:512

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71506-032
Product Ndc: 71506-032
Product Ndc Digits: 71506032
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Norepinephrine Bitartrate
Proprietary Name Suffix: [empty]
Nonproprietary Name: Norepinephrine Bitartrate
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
Establishment Name: Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
Establishment Fei: [empty]
Substance Name: NOREPINEPHRINE BITARTRATE
Active Ingredients Info: 32 mg/250 mL
History Active Ingredients Raw: NOREPINEPHRINE BITARTRATE
History Active Ingredients Info Raw: 32 mg/250 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 71506-032-58
Package Ndc: 71506-032-58
Package Ndc Digits: 7150603258
Package Ndc11: 71506003258
Package Description: 250 mL in 1 BAG (71506-032-58)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:512
Source Row Number: 512
Source Row Hash: 641e405e6d95fa34fc32f0e206f7d03e22caa775aa85577dddef14a42183b5e7
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71506-032",
    "DEASCHEDULE": "",
    "LABELERNAME": "Fresenius Kabi Compounding LLC DBA Fagron Sterile Services",
    "SUBSTANCENAME": "NOREPINEPHRINE BITARTRATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71506-032-58",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Norepinephrine Bitartrate",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Norepinephrine Bitartrate",
    "PACKAGEDESCRIPTION": "250 mL in 1 BAG (71506-032-58) ",
    "ACTIVEINGREDIENTSINFO": "32 mg/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:512
Source Row Number: 512
Status Scope: package
Lookup Ndc: 71506-032-58
Lookup Ndc Digits: 7150603258
Product Ndc: 71506-032
Product Ndc Digits: 71506032
Package Ndc: 71506-032-58
Package Ndc Digits: 7150603258
Package Ndc11: 71506003258
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 641e405e6d95fa34fc32f0e206f7d03e22caa775aa85577dddef14a42183b5e7
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51